JNJ-64041757 (JNJ-757), a Live, Attenuated, Double-Deleted Listeria monocytogenes–Based Immunotherapy in Patients With NSCLC: Results From Two Phase 1 Studies-Reference-Cited by-同舟云学术

JNJ-64041757 (JNJ-757), a Live, Attenuated, Double-Deleted Listeria monocytogenes–Based Immunotherapy in Patients With NSCLC: Results From Two Phase 1 Studies

Published:2021-02 Issue:2 Volume:2 Page:100103
ISSN:2666-3643
Container-title:JTO Clinical and Research Reports
language:en
Short-container-title:JTO Clinical and Research Reports

Author:

Brahmer Julie R.,Johnson Melissa L.,Cobo Manuel,Viteri Santiago,Sarto Juan Coves,Sukari Ammar,Awad Mark M.,Salgia Ravi,Papadimitrakopoulou Vali A.,Rajan Arun,Bandyopadhyay Nibedita,Allred Alicia J.,Wade Mark,Mason Gary E.,Zudaire Enrique,Knoblauch Roland E.,Stone Nicole,Lorenzi Matthew V.,Hassan Raffit

Publisher

Elsevier BV

Reference35 articles.

1. Estimating the global cancer incidence and mortality in 2018: GLOBOCAN sources and methods;Ferlay;Int J Cancer,2019

2. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries [published correction appears in CA Cancer J Clin. 2020;70:313];Bray;CA Cancer J Clin,2018

3. Non-small cell lung cancer: epidemiology, risk factors, treatment, and survivorship;Molina;Mayo Clin Proc,2008

4. Five-year survival and correlates among patients with advanced melanoma, renal cell carcinoma, or non-small cell lung cancer treated with nivolumab;Topalian;JAMA Oncol,2019

Cited by 16 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Exploiting bacteria for cancer immunotherapy;Nature Reviews Clinical Oncology;2024-06-05

2. A Review of Clinical Trials Involving Genetically Modified Bacteria, Bacteriophages and Their Associated Risk Assessments;Applied Biosafety;2024-05-08

3. Cancer cell-intrinsic PD-1: Its role in malignant progression and immunotherapy;Biomedicine & Pharmacotherapy;2023-11

4. Listeria monocytogenes: a promising vector for tumor immunotherapy;Frontiers in Immunology;2023-10-06

5. Intravenous administration of BCG in mice promotes natural killer and T cell-mediated antitumor immunity in the lung;Nature Communications;2023-10-04